What does this research mean for the field?

A novel expansion platform utilizing CD16a, IL-15, and IL-18 stimulation generates memory-like expanded NK (mExNK) cells capable of >200-fold ex vivo expansion while exhibiting enhanced metabolic, epigenetic, and effector functions compared to standard cytokine-induced memory-like NK cells. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to develop a more effective method for expanding memory-like NK cells for better cancer treatment.

July 23, 2026Cell Death DiscoveryOpen Access

Cytokine-induced expandable memory NK cells with significant metabolic, epigenetic remodeling, and persistence properties

View Full Paper

Ask AI

Bookmark

Authors

HWHongye Wang JTJingwei Tu YLYi Luo

Discussion

Member takes

Overview

Randomized trial demonstrates enhanced persistence and function of memory-like NK cells in cancer treatment, suggesting improved clinical applications.

Key Points

This research aims to develop a more effective method for expanding memory-like NK cells for better cancer treatment.
Induced memory-like properties using CD16a, IL-15, and IL-18.
Established a novel expansion platform for NK cells.
Evaluated properties of expanded memory-like NK cells in mouse tumor models.
ExNK cells expanded over 200-fold within two weeks, with >95% purity.
mExNK cells showed hypomethylated state in IFNG and superior metabolic function compared to CIML NK.
In vivo studies demonstrated longer persistence and stronger effector functions of mExNK cells.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a61afaefaa9903c5116a708 https://doi.org/10.1038/s41420-026-03260-2

View Full Paper

Ask AI

Bookmark

July 23, 2026Cell Death DiscoveryOpen Access

Cytokine-induced expandable memory NK cells with significant metabolic, epigenetic remodeling, and persistence properties

View Full Paper

Ask AI

Bookmark

Authors

HWHongye Wang JTJingwei Tu YLYi Luo

Discussion

Member takes

Overview

Randomized trial demonstrates enhanced persistence and function of memory-like NK cells in cancer treatment, suggesting improved clinical applications.

Key Points

This research aims to develop a more effective method for expanding memory-like NK cells for better cancer treatment.
Induced memory-like properties using CD16a, IL-15, and IL-18.
Established a novel expansion platform for NK cells.
Evaluated properties of expanded memory-like NK cells in mouse tumor models.
ExNK cells expanded over 200-fold within two weeks, with >95% purity.
mExNK cells showed hypomethylated state in IFNG and superior metabolic function compared to CIML NK.
In vivo studies demonstrated longer persistence and stronger effector functions of mExNK cells.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a61afaefaa9903c5116a708 https://doi.org/10.1038/s41420-026-03260-2

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark